Corina Glanzmann1, Bernhard Frey2, Priska Vonbach3, Christoph R Meier4,5. 1. Hospital Pharmacy, University Children's Hospital Zürich, Steinwiesstrasse 75, 8032, Zürich, Switzerland. pharma@kispi.uzh.ch. 2. Department of Intensive Care and Neonatology, University Children's Hospital Zürich, Steinwiesstrasse 75, 8032, Zürich, Switzerland. 3. Hospital Pharmacy, University Children's Hospital Zürich, Steinwiesstrasse 75, 8032, Zürich, Switzerland. 4. Hospital Pharmacy, University Hospital Basel, Spitalstrasse 26, 4031, Basel, Switzerland. 5. Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Abstract
BACKGROUND: Acute kidney injury (AKI) is a serious condition in critically ill children. Nephrotoxic medication exposure is a common contributing factor to AKI, but little literature is available in pediatrics. The aim of the present study was to assess potential associations between drugs and the risk of developing AKI. METHODS: We performed a retrospective case-control study in a pediatric intensive care unit (PICU). Cases were patients who developed AKI during PICU stay. Patients without AKI served as controls and were matched to cases by age and gender in a one-to-one ratio. RESULTS: One hundred case-control pairs were included. Cases were not statistically different from controls with regard to median weight and main diagnoses, but differed with regard to the need for mechanical ventilation, severity of illness, and median length of PICU stay. Multivariate models revealed a statistically significant higher risk of developing AKI for patients treated with metamizole, morphine, paracetamol, and tropisetron. A similar risk could be shown for medication groups, namely glucocorticoids, betalactam antibiotics, opioids, and non-steroidal anti-inflammatory drugs. CONCLUSIONS: The results suggest that drugs are associated with acute renal dysfunction in critically ill children, but the multifactorial causes of AKI should be kept in mind.
BACKGROUND:Acute kidney injury (AKI) is a serious condition in critically ill children. Nephrotoxic medication exposure is a common contributing factor to AKI, but little literature is available in pediatrics. The aim of the present study was to assess potential associations between drugs and the risk of developing AKI. METHODS: We performed a retrospective case-control study in a pediatric intensive care unit (PICU). Cases were patients who developed AKI during PICU stay. Patients without AKI served as controls and were matched to cases by age and gender in a one-to-one ratio. RESULTS: One hundred case-control pairs were included. Cases were not statistically different from controls with regard to median weight and main diagnoses, but differed with regard to the need for mechanical ventilation, severity of illness, and median length of PICU stay. Multivariate models revealed a statistically significant higher risk of developing AKI for patients treated with metamizole, morphine, paracetamol, and tropisetron. A similar risk could be shown for medication groups, namely glucocorticoids, betalactam antibiotics, opioids, and non-steroidal anti-inflammatory drugs. CONCLUSIONS: The results suggest that drugs are associated with acute renal dysfunction in critically ill children, but the multifactorial causes of AKI should be kept in mind.
Authors: Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates Journal: J Am Soc Nephrol Date: 2005-09-21 Impact factor: 10.121
Authors: A Akcan-Arikan; M Zappitelli; L L Loftis; K K Washburn; L S Jefferson; S L Goldstein Journal: Kidney Int Date: 2007-03-28 Impact factor: 10.612
Authors: Michael Zappitelli; Pierre-Luc Bernier; Richard S Saczkowski; Christo I Tchervenkov; Ronald Gottesman; Adrian Dancea; Ayaz Hyder; Omar Alkandari Journal: Kidney Int Date: 2009-07-29 Impact factor: 10.612
Authors: Jason M Misurac; Chad A Knoderer; Jeffrey D Leiser; Corina Nailescu; Amy C Wilson; Sharon P Andreoli Journal: J Pediatr Date: 2013-01-26 Impact factor: 4.406
Authors: Emily L Joyce; Sandra L Kane-Gill; Priyanka Priyanka; Dana Y Fuhrman; John A Kellum Journal: J Am Soc Nephrol Date: 2019-09-09 Impact factor: 10.121
Authors: Kanaan Mansoor; Murad Kheetan; Saba Shahnawaz; Anna P Shapiro; Eva Patton-Tackett; Larry Dial; Gary Rankin; Prasanna Santhanam; Antonios H Tzamaloukas; Tibor Nadasdy; Joseph I Shapiro; Zeid J Khitan Journal: BMC Nephrol Date: 2017-12-29 Impact factor: 2.388